FDA Inspection 989604 — Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
The FDA completed an inspection of Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. on September 23, 2016 in Tianjin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 23, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tianjin (China)